Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

GP-3269 on track for clinical testing

May 17, 1996

SB-204269 in phase I for epilepsy

May 17, 1996

Ketoconazole: Potential treatment for depression?

May 17, 1996

Scios to copromote venlafaxine with Wyeth-Ayerst

May 17, 1996

5-HT1D antagonists disclosed by SmithKline Beecham

May 17, 1996

Pfizer claims 5-HT1 agonists and antagonists for CNS disorders

May 17, 1996

Sertindole clinical trial results reported at APA meeting

May 17, 1996

NIH scientists report ligands for alpha5-containing GABA-A receptors

May 17, 1996

Paroxetine approved for new indication

May 17, 1996

Kappa-opioid agonists reported by Pfizer

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 7, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
Another rebound as Sangamo inks $1.4B capsid deal with Lilly
BioWorld
Sangamo Therapeutics Inc. is adding a much-needed $18 million up-front payment in a neurology-focused deal with Eli Lilly and Co. that could bring up to an...
Impact of Trump tariffs on med tech proving difficult to anticipate
BioWorld MedTech
The Trump administration’s declaration of a new round of tariffs did not sit well with trade associations, but the impact of those tariffs may vary somewhat by...